Teladoc (TDOC) +2% on addition of GLP-1 self-pay option with Lilly
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Truist Securities Reiterates Hold Rating on Teladoc (TDOC)
March 6, 2025 2:09 PM ESTTruist Securities analyst Jaliendra Singh reiterated a Hold rating and $10.00 price target on Teladoc (NYSE: TDOC)
The analyst comments "This morning, TDOC announced a pharmacy integration agreement with Gifthealth (private), a pharmacy partner for Eli Lilly's LillyDirect (LLY, Buy, Devarakonda). The partnership is expected to... More
